Emergent Biosolutions EBS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's accounts payable?
- Emergent Biosolutions (EBS) reported accounts payable of $39.5M in Q1 2026.
- How has Emergent Biosolutions's accounts payable changed year-over-year?
- Emergent Biosolutions's accounts payable decreased by 32.0% year-over-year, from $58.1M to $39.5M.
- What is the long-term trend for Emergent Biosolutions's accounts payable?
- Over 5 years (2020 to 2025), Emergent Biosolutions's accounts payable has grown at a -16.4% compound annual growth rate (CAGR), from $136.1M to $55.6M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.